These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3066250)

  • 1. [The prostate and male hormones after 50 years of age].
    de Lignières B; Martin PM
    Ann Med Interne (Paris); 1988; 139(6):405-9. PubMed ID: 3066250
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurements of prolactin and androgens in patients with prostatic disease.
    Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
    Surg Forum; 1977; 28():568-9. PubMed ID: 83009
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.
    Dorgan JF; Albanes D; Virtamo J; Heinonen OP; Chandler DW; Galmarini M; McShane LM; Barrett MJ; Tangrea J; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1069-74. PubMed ID: 9865423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate.
    Scarano WR; Vilamaior PS; Taboga SR
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov; 288(11):1190-200. PubMed ID: 17031809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer.
    Carpenter WR; Robinson WR; Godley PA
    J Natl Cancer Inst; 2008 Feb; 100(3):158-9. PubMed ID: 18230791
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgenic hormones and prostate cancer risk: status and prospects.
    Gann PH
    IARC Sci Publ; 2002; 156():283-8. PubMed ID: 12484188
    [No Abstract]   [Full Text] [Related]  

  • 7. [Androgens and prostate: basic research and clinical data].
    Martini PM; Rossi D; Muracciole X; Saussine C; Raynaud JP; Tostain J
    Prog Urol; 2004 Nov; 14(5):751-67. PubMed ID: 15747623
    [No Abstract]   [Full Text] [Related]  

  • 8. Androgens and prostate cancer risk: a prospective study.
    Wirén S; Stocks T; Rinaldi S; Hallmans G; Bergh A; Stenman UH; Kaaks R; Stattin P
    Prostate; 2007 Aug; 67(11):1230-7. PubMed ID: 17562541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and aspects of prostate disease.
    Prezioso D; Denis LJ; Klocker H; Sciarra A; Reis M; Naber K; Lobel B; Pacik D; Griffiths K
    Int J Urol; 2007 Jan; 14(1):1-16. PubMed ID: 17199853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
    Shao Q; Song J; Zhou ZJ; Du LD
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control studies of selected hormones and prostate cancer. An epidemiologic review.
    Flanders WD
    Ala J Med Sci; 1986 Oct; 23(4):439-43. PubMed ID: 3789318
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment. Sex hormones and the risk of incident prostate cancer.
    Thomas JA; Bañez L; Freedland SJ
    Urology; 2010 Nov; 76(5):1040-1. PubMed ID: 21056251
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma hormone levels before and after orchiectomy in prostate cancer patients.
    Fiet J; Villette JM; Bertagna C; de Géry A; Hucher M; Husson JM; Raynaud JP
    Prog Clin Biol Res; 1987; 243A():33-44. PubMed ID: 3659004
    [No Abstract]   [Full Text] [Related]  

  • 14. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
    Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-prostatic androgen levels during various androgen-blockade regimens.
    Nishiyama T
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum chromogranin A in prostate cancer. Preliminary results].
    Reale MG; Marchei GG; Boccia S; Cristofoletti C; Caporossi E; Marchei M; Izzo P; Marchei P
    Minerva Med; 1999; 90(7-8):221-3. PubMed ID: 10719423
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostatorectal fistula 14 years following brachytherapy for prostate cancer.
    Davis JW; Schellhammer PF
    J Urol; 2001 Jan; 165(1):189. PubMed ID: 11125400
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of serum ceruloplasmin levels in prostate diseases: preliminary investigation of the effect of therapeutic estrogens on serum levels of this protein].
    Bélanger L
    Union Med Can; 1971 Aug; 100(8):1554-62. PubMed ID: 5561247
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prolactin receptors in the prostate].
    Wylot M; Laszczyńska M; Chorzepa K
    Pol Merkur Lekarski; 2006 Nov; 21(125):492-4. PubMed ID: 17345848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen testing. An essential guide to its use and meaning.
    Marks SH
    Adv Nurse Pract; 2001 Apr; 9(4):38-9, 43-4. PubMed ID: 12420434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.